Skip to main content

Denver startup raises $2M to take its allergy treatment to the masses

The treatment is meant to desensitize the immune systems of patients over time.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.